UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020354
Receipt number R000023507
Scientific Title A Prospective Observational Study on the Carbon Ion Therapy for Localized and Locally Advanced Prostate Cancer
Date of disclosure of the study information 2015/12/28
Last modified on 2023/12/25 14:19:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Observational Study on the Carbon Ion Therapy for Localized and Locally Advanced Prostate Cancer

Acronym

A Prospective Observational Study on the Carbon Ion Therapy for Advanced Prostate Cancer (iROCK-PR01 Study)

Scientific Title

A Prospective Observational Study on the Carbon Ion Therapy for Localized and Locally Advanced Prostate Cancer

Scientific Title:Acronym

A Prospective Observational Study on the Carbon Ion Therapy for Advanced Prostate Cancer (iROCK-PR01 Study)

Region

Japan


Condition

Condition

Localized or locally advanced prostate cancer

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To confirm the safety and efficacy of the Carbon Ion Therapy for T1-T3N0M0 localized or locally advanced prostate cancer in Kanagawa cancer center.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Incidence of late-phase rectal adverse event with CTCAE Grade 2 or more

Key secondary outcomes

1) Incidence of early and late adverse events
2) 5-year biochemical and clinical recurrence
3) 5-year overall survival
4) Local control rate
5) ECOG Performance Status (PS)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1) Histologically proven primary prostate adenocarcinoma
2) cT1c,T2a,T2b,T2c,T3a,T3bN0M0
(2009, UICC 7th)
3) Performance status is 0, 1 or 2
4) Under 20 years old of age at registration
5) Untreated patient in prostate cancer, excluding neoadjuvant endocrine therapy.
6) Patients are informed for diagnosis of prostate cancer and independently agree with this study on carbon-ion radiotherapy

Key exclusion criteria

1) Past history of radiotherapy in the irradiation lesion concerned
2) Multiple active malignancies
3) Medically or psychologically inappropriate status for this study judged by physicians

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Katoh

Organization

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Division name

Department of Carbon-ion Radiotherapy

Zip code

241-8515

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

TEL

045-520-2222

Email

hkatoh@kcch.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Katoh

Organization

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Division name

Ion-beam Radiation Oncology Center

Zip code

241-8515

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

TEL

045-520-2222

Homepage URL


Email

hkatoh@kcch.jp


Sponsor or person

Institute

Kanagawa Cancer Center,
Kanagawa Prefectural Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

Kanagawa Prefectual Hospital Organization

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Kanagawa Cancer Center IRB

Address

2-3-2, Nakao, Asahi-ku, YOKOHAMA, Kanagawa Pref.

Tel

0455202222

Email

clinical_trials@kcch.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神奈川県立病院機構
神奈川県立がんセンター
Kanagawa Cancer Center,
Kanagawa Prefectural Hospital Organization


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

11

Results

This study confirmed safety and efficacy comparable to those reported from prior facilities.

Results date posted

2023 Year 12 Month 21 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 29 Day

Date of IRB

2015 Year 10 Month 29 Day

Anticipated trial start date

2015 Year 11 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry

2026 Year 03 Month 31 Day

Date trial data considered complete

2026 Year 03 Month 31 Day

Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information

Study Design: Single-arm prospective observational study
Subject Recruitment: Patients who visits Kanagawa Cancer Center during the registration period -i.e., from November to December 2015, and who fulfilling the inclusion and exclusion criteria


Management information

Registered date

2015 Year 12 Month 25 Day

Last modified on

2023 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023507


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name